loratadine has been researched along with Pink Eye in 4 studies
Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The possible effectiveness of loratadine in the treatment of allergic cough was assessed in 20 patients with allergic rhinoconjunctivitis and cough due to Parietaria judaica during the pollen season (April to July 1993)." | 9.08 | Loratadine in the treatment of cough associated with allergic rhinoconjunctivitis. ( Bianchi, B; Buscaglia, S; Canonica, GW; Catrullo, A; Ciprandi, G; Marchesi, E, 1995) |
| "In this study, emedastine was more efficacious than loratadine for reducing the itching and redness associated with allergic conjunctivitis in the human conjunctival allergen challenge model." | 5.10 | A randomized, double-blind, placebo-controlled comparison of emedastine 0.05% ophthalmic solution with loratadine 10 mg and their combination in the human conjunctival allergen challenge model. ( Abelson, MB; Kaplan, AP, 2002) |
| "The possible effectiveness of loratadine in the treatment of allergic cough was assessed in 20 patients with allergic rhinoconjunctivitis and cough due to Parietaria judaica during the pollen season (April to July 1993)." | 5.08 | Loratadine in the treatment of cough associated with allergic rhinoconjunctivitis. ( Bianchi, B; Buscaglia, S; Canonica, GW; Catrullo, A; Ciprandi, G; Marchesi, E, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mullol, J | 1 |
| Valero, A | 1 |
| Alobid, I | 1 |
| Ciprandi, G | 1 |
| Buscaglia, S | 1 |
| Catrullo, A | 1 |
| Marchesi, E | 1 |
| Bianchi, B | 1 |
| Canonica, GW | 1 |
| Tarchalska-Kryńska, B | 1 |
| Zawisza, E | 1 |
| Abelson, MB | 1 |
| Kaplan, AP | 1 |
3 trials available for loratadine and Pink Eye
| Article | Year |
|---|---|
Loratadine in the treatment of cough associated with allergic rhinoconjunctivitis.
Topics: Adult; Aged; Allergens; Conjunctivitis; Cough; Female; Humans; Loratadine; Male; Middle Aged; Pollen | 1995 |
[Test for efficacy of cetirizine and loratadine as a treatment for seasonal allergic rhinitis in a 6 week cross-over comparative study].
Topics: Adolescent; Adult; Cetirizine; Conjunctivitis; Cross-Over Studies; Female; Humans; Loratadine; Male; | 1994 |
A randomized, double-blind, placebo-controlled comparison of emedastine 0.05% ophthalmic solution with loratadine 10 mg and their combination in the human conjunctival allergen challenge model.
Topics: Adult; Allergens; Anti-Allergic Agents; Benzimidazoles; Conjunctivitis; Double-Blind Method; Drug Th | 2002 |
1 other study available for loratadine and Pink Eye
| Article | Year |
|---|---|
The nose - from symptoms to evidence-based medicine.
Topics: Conjunctivitis; Evidence-Based Medicine; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; | 2007 |